Welcome Guest | Register / Login

Global Molecular Diagnostics Market Report: 2013 Edition

1. Diagnostics: An Overview    

1.1 In Vitro Diagnostics    
1.2 Molecular Diagnostics    

2. Diagnostics Market Structure    

2.1 In Vitro Diagnostics (IVD) Market    
-Market Value
-Market Segments

2.2 Global Molecular Diagnostics Market
-Market Value
-Market Segments

2.2.1 Molecular Diagnostics - Segment Analysis

a) HPV
-Market Value
-Penetration Rate

b) CT/NG
-Market Value    

2.2.2 Global Genetic Testing Market
-Market Value    

3. Market Dynamics    

3.1 Industry Trends and Developments

3.1.1 Molecular Diagnostics in Oncology: Focus on Personalized Treatment
3.1.2 Growing M&A Activity in the Molecular Diagnostics Landscape    
3.1.3 Reimbursement    
3.1.4 Penetrating Point of Care Diagnostics
3.1.5 Emerging Korean Molecular Diagnostics Business

3.2 Growth Drivers    

3.2.1 Increasing Prevalence of Cancer
3.2.2 Rising Demand for Better Healthcare Options
3.2.3 Diabetic Population    
3.2.4 Growing Ageing Population (+60 Years)
3.2.5 Ameliorating Economic Conditions    
3.2.6 Increasing Insurance Density    
3.2.7 Low Penetration of Vitamin D Tests
3.2.8 Growth in Genetic Testing Procedures

3.3 Challenges    

3.3.1 Stringent Regulations    
3.3.2 Mounting Price Pressure    

4. Competitive Landscape    
-Competitive Overview
-Market Share

5. Company Profiles    

5.1 Hologic, Inc.    

5.1.1 Business Overview    
5.1.2 Financial Overview    
5.1.3 Business Strategies    
-Focus on Research & Development
-Expansion via Strategic Acquisitions

5.2 Abbott Laboratories    

5.2.1 Business Overview    
5.2.2 Financial Highlights    
5.2.3 Business Strategies
-Mergers and Acquisitions
-Expansion in Emerging Markets

5.3 Roche Holdings AG    

5.3.1 Business Overview    
5.3.2 Financial Overview    
5.3.3 Business Strategies
-Focus on Innovative Diagnostics
-Expertise in Molecular Biology

5.4 Novartis AG    

5.4.1 Business Overview    
5.4.2 Financial Overview    
5.4.3 Business Strategies
-Strong Product Pipeline
-Leadership in Innovation

6. Market Outlook    

6.1 Market Forecast    
6.2 Forecast Methodology

6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis    
6.2.3 Regression Analysis    

List of Charts

IVD Market – Segments by Technology
Molecular Diagnostcs – Traditional Process
Main Purposes of Molecular Diagnostics
Global Diagnostics Market (2005-2012E)
Global IVD Market (2006-2011)
IVD Market Share by Major Segments (2012)
Global Molecular Diagnostics Market (2005-2012)
Molecular Diagnostics Market Share by Segment
Infectious Disease Market Segmentation
HPV Testing Market Penetration Rates in the US (2010-2013E)
Global Genetic Testing Market (2007-2011)
Current Standards of Care in Various Therapeutic Areas (2011)
Number of IVD M&A’s per Year (2009-2012)
Number of M&A Deals According to Primary IVD Target Company Focus (2009-2012)
Number of IVD Partnership Deals by Deal Type
Number of Cancer Cases Worldwide (2007-2011)
World Population with Diabetes, Age Group 20-79 years (2006-2012)
Global Ageing Population (2005-2013F)
Global GDP (2001-2011)
World GDP per Capita (2005-2011)
Global Insurance Density (2004-2011)
Global Vitamin D Market (2007-2011)
Vitamin D Tests Penetration by Region (2011E)
Number of Genetic Tests and Laboratories Available Worldwide (1993-2011)
Worldwide Number of Diseases with Availability of Genetic Testing (2005-2011)
Global IVD Market Share by Company (2012)
Global Molecular Diagnostics Market Share by Company (2012)
Global CT/GC Market Share by Leading Companies (2011)
Hologic’s Revenue Share by Business Segment (2012)
Hologic’s Revenues and Net Income (2008-2012)
Abbott Laboratories Revenue – Share by Segments (2012)
Abbott Laboratories Revenue (2008-2012)
Roche’s Revenues by Business Segments (2012)
Roche’s Revenues and Net Income (2008-2012)
Novartis’ Revenue Share by Business Segments (2012)
Novartis’ Revenues and Net Income (2008-2012)
Global Molecular Diagnostics Market Forecast (2010-2015F)

List of Tables

Global HPV Market Model (2011-2015E)
CT/NG Market Model (2011-2015E)
Main M&A Deals in the Molecular Diagnostics Sector (2009-2012)
Patients Worldwide Waiting for Better Treatment Options (2011)
IVD Market Key Players-by Segments
Dependent & Independent Variables (2007-2012)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output

Why http://www.marketreportsonline.com/
Published By :Koncept Analytics
Price
Live Chat
Live Chat by Comm100